Biological and lifestyle factors contributing to Tau in women at risk for Alzheimer's disease.
在有阿尔茨海默病风险的女性中,生物和生活方式因素会导致 Tau 蛋白的形成。
基本信息
- 批准号:10591159
- 负责人:
- 金额:$ 102.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-09-15 至 2028-05-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAdverse effectsAlzheimer&aposs DiseaseAlzheimer&aposs Disease PathwayAlzheimer&aposs disease pathologyAlzheimer&aposs disease riskAlzheimer’s disease biomarkerAnti-Inflammatory AgentsAutoimmune DiseasesBiologicalBiological AssayBiological FactorsBrainCentral Nervous SystemCerebrospinal FluidCognitionCognitiveCognitive deficitsDataData CollectionDementiaDiseaseDisease OutcomeElderlyEndocrineEnrollmentFemaleFundingGeneticGenetic RiskGonadal Steroid HormonesHealthHormonesImmuneImmune responseImpaired cognitionIndividualInflammationInflammatoryInflammatory ResponseInterleukin-6InterventionInvestigationJointsKnowledgeLife StyleLife Style ModificationLinkMeasuresMediatingMemoryMenopauseModelingObservational StudyObstructive Sleep ApneaOutcomeParticipantPathogenesisPathologicPathologyPathway interactionsPerformancePhysical activityPhysical assessmentPilot ProjectsPlayPositron-Emission TomographyPredispositionProteinsReceptors, Tumor Necrosis Factor, Type IIReportingReproductive HistoryResearch PriorityRisk FactorsRisk ReductionRoleSample SizeSamplingSeveritiesSex DifferencesSleepStressSymptomsTNF geneTNFRSF1B geneTestosteroneTimeTumor MarkersUnited States National Institutes of HealthWomanWorkassociated symptomcognitive functioncytokinediet and exerciseexperiencefollow up assessmentimprovedlifestyle factorslifestyle interventionmenmild cognitive impairmentmodifiable riskneuroimagingneuroinflammationolder womenpharmacologicreceptorrecruitsedentary lifestylesexsex disparitytau Proteinstau aggregationtau functiontau-1therapeutic target
项目摘要
PROJECT SUMMARY/ABSTRACT Growing evidence reports that women show a more aggressive profile of
Alzheimer's disease (AD) than men with greater pathological tau burden and steeper cognitive decline; yet the
reasons for these sex differences are poorly understood. Sex differences in AD point to sex-disparate causal
pathways as well as sex-specific therapeutic targets. Neuroinflammation (N-Inf) is one candidate casual pathway
that shows sex disparities and plays a central role in AD pathogenesis with close ties to both tau and cognitive
decline. Women tend to have a more robust immune/inflammatory response and comprise 80% of autoimmune
disease cases. Moreover, our own preliminary work in the Alzheimer's Disease Neuroimaging Initiative indicated
that women may be more susceptible than men to the adverse effect of N-Inf, particularly the markers of TNFα,
IL6 and their receptors on cerebrospinal fluid (CSF) levels of phosphorylated tau (p-tau) and cognitive function.
There are also lifestyle factors such as physical activity and obstructive sleep apnea (OSA) known to influence N-
Inf and relate to tau and cognitive decline and to do so differently in women versus men. Our own preliminary data
highlight sedentary behavior and obstructive sleep apnea as two modifiable risk factors that show strong
associations with N-Inf, tau and/or cognitive function in older women, and thus stress the need to further
understand how and to what degree these lifestyle interventions could reduce AD risk. Together, these findings
led us to this proposed observational study that will examine how N-Inf markers (specifically TNFα, TNFR2, IL6
and IL6R) and the modifiable risk factors that influence N-Inf relate to tau accumulation and cognitive decline in
older women at-risk for AD by way of mild cognitive deficits and genetic risk. Moreover, we will explore how sex
hormones, particularly testosterone, contribute to these relationships given their anti-inflammatory and central
nervous system effects and often contributing role to sex differences. To achieve this, we propose to measure
CSF N-Inf markers, physical activity, OSA, and circulating sex hormones in a sample of 100 older women at-risk
for AD and relate these measures to changes in cognitive function and accumulation of tau, measured via
positron emission tomography (PET), over a two-year period. This study will build upon a state-funded, pilot
study by increasing the sample size and adding longitudinal assessments in order to conduct a rigorous
examination of our hypotheses. In keeping with NIH research priorities, after 5 years of potential funding, this
project will help to close critical gaps in our understanding of sex differences in AD by examining under-explored
yet highly-relevant mechanisms that may contribute to the greater pathology and steeper cognitive decline in
women on the AD trajectory. Furthermore, our findings will inform risk reduction strategies that influence these
mechanisms – an important focus given current the lack of disease-modifying treatments.
越来越多的证据表明,女性表现出更积极的个人形象,
阿尔茨海默病(AD)的发病率高于男性,病理性tau蛋白负荷更大,认知能力下降更严重;然而,
对这些性别差异的原因知之甚少。AD的性别差异表明性别差异的因果关系
途径以及性别特异性治疗靶点。神经炎症(N-Inf)是一个候选的因果通路
这显示了性别差异,并在AD发病机制中起着核心作用,与tau蛋白和认知功能密切相关。
下降女性往往有更强大的免疫/炎症反应,占自身免疫性疾病的80%。
疾病病例。此外,我们自己在阿尔茨海默病神经成像倡议中的初步工作表明,
女性可能比男性更容易受到N-Inf的不良影响,特别是TNFα标志物,
IL 6及其受体对脑脊液(CSF)磷酸化tau(p-tau)水平和认知功能的影响。
还有一些生活方式因素,如身体活动和阻塞性睡眠呼吸暂停(OSA),已知会影响N-
与tau蛋白和认知能力下降有关,并在女性和男性中以不同的方式进行。我们自己的初步数据
强调久坐行为和阻塞性睡眠呼吸暂停是两个可改变的风险因素,
与N-Inf,tau和/或老年妇女的认知功能相关,因此强调需要进一步
了解这些生活方式干预如何以及在多大程度上可以降低AD风险。总之,这些发现
引导我们进行这项观察性研究,研究N-Inf标志物(特别是TNFα、TNFR 2、IL 6)
和IL 6 R)和影响N-Inf的可改变的风险因素与tau蛋白积累和认知能力下降有关,
老年妇女有轻度认知缺陷和遗传风险的AD风险。此外,我们将探讨性如何
激素,特别是睾酮,有助于这些关系,因为它们具有抗炎和中枢神经系统功能。
神经系统的影响,并往往有助于性别差异的作用。为了实现这一目标,我们建议
100例高危老年女性的CSF N-Inf标记物、体力活动、OSA和循环性激素
并将这些测量与认知功能的变化和tau的积累相关,通过
正电子发射断层扫描(PET),为期两年。这项研究将建立在一个国家资助的试点,
研究通过增加样本量和增加纵向评估,以进行严格的
检查我们的假设。为了与NIH的研究重点保持一致,经过5年的潜在资助,
该项目将有助于缩小我们对AD性别差异理解的关键差距,
然而,高度相关的机制,可能有助于更大的病理和陡峭的认知下降,
在AD轨迹上的女性。此外,我们的研究结果将为影响这些风险的风险降低策略提供信息。
机制-一个重要的焦点,鉴于目前缺乏疾病修饰治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SARAH BANKS其他文献
SARAH BANKS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SARAH BANKS', 18)}}的其他基金
Understanding Biological and Lifestyle Contributions to Alzheimer's Disease Pathology and Clinical Profiles in Black Women: Defining Prevention Targets in High Risk Groups
了解生物学和生活方式对黑人女性阿尔茨海默病病理学和临床特征的影响:确定高危人群的预防目标
- 批准号:
10591000 - 财政年份:2022
- 资助金额:
$ 102.59万 - 项目类别:
Sex-specific cognitive expression and risk in preclinical Alzheimer's disease
临床前阿尔茨海默病的性别特异性认知表达和风险
- 批准号:
10336899 - 财政年份:2019
- 资助金额:
$ 102.59万 - 项目类别:
Sex-specific cognitive expression and risk in preclinical Alzheimer's disease
临床前阿尔茨海默病的性别特异性认知表达和风险
- 批准号:
10017125 - 财政年份:2019
- 资助金额:
$ 102.59万 - 项目类别:
Sex-specific cognitive expression and risk in preclinical Alzheimer's disease
临床前阿尔茨海默病的性别特异性认知表达和风险
- 批准号:
10646223 - 财政年份:2019
- 资助金额:
$ 102.59万 - 项目类别:
Sex-specific cognitive expression and risk in preclinical Alzheimer's disease
临床前阿尔茨海默病的性别特异性认知表达和风险
- 批准号:
10200671 - 财政年份:2019
- 资助金额:
$ 102.59万 - 项目类别:
Sex-specific cognitive expression and risk in preclinical Alzheimer's disease
临床前阿尔茨海默病的性别特异性认知表达和风险
- 批准号:
10416197 - 财政年份:2019
- 资助金额:
$ 102.59万 - 项目类别:
Sex-specific cognitive expression and risk in preclinical Alzheimer's disease
临床前阿尔茨海默病的性别特异性认知表达和风险
- 批准号:
10417213 - 财政年份:2019
- 资助金额:
$ 102.59万 - 项目类别:
Sex-specific cognitive expression and risk in preclinical Alzheimer's disease
临床前阿尔茨海默病的性别特异性认知表达和风险
- 批准号:
10634349 - 财政年份:2019
- 资助金额:
$ 102.59万 - 项目类别:
Project 1: The relationship between Neuropsychological Testing and MRI, PET, and
项目 1:神经心理测试与 MRI、PET 和 MRI 之间的关系
- 批准号:
9312828 - 财政年份:
- 资助金额:
$ 102.59万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 102.59万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 102.59万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 102.59万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 102.59万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 102.59万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 102.59万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 102.59万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 102.59万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 102.59万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 102.59万 - 项目类别:
Research Grant